1,4-phenylenebis(methylene)selenocyanate and sirolimus

1,4-phenylenebis(methylene)selenocyanate has been researched along with sirolimus in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
El-Bayoumy, K; Facompre, ND; Pinto, JT; Sinha, I; Sinha, R	1

Other Studies

1 other study(ies) available for 1,4-phenylenebis(methylene)selenocyanate and sirolimus

Article	Year
Remarkable inhibition of mTOR signaling by the combination of rapamycin and 1,4-phenylenebis(methylene)selenocyanate in human prostate cancer cells. International journal of cancer, 2012, Nov-01, Volume: 131, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Carrier Proteins; Cell Line, Tumor; Cell Proliferation; Humans; Male; Organoselenium Compounds; Phosphorylation; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Rapamycin-Insensitive Companion of mTOR Protein; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases	2012

Article

Year

Remarkable inhibition of mTOR signaling by the combination of rapamycin and 1,4-phenylenebis(methylene)selenocyanate in human prostate cancer cells.

International journal of cancer, 2012, Nov-01, Volume: 131, Issue:9

Topics: Antineoplastic Combined Chemotherapy Protocols; Carrier Proteins; Cell Line, Tumor; Cell Proliferation; Humans; Male; Organoselenium Compounds; Phosphorylation; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Rapamycin-Insensitive Companion of mTOR Protein; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases

2012